ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 10660 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 10660; 2) Community: the network communities that were significantly associated with the response to NSC 10660; 3) Molecule: the relationships between components within communities and NSC 10660; 4) MDR: the compounds that were significantly associated with the NSC 10660.

NSC Compound Enrichment Correlation
NSC 747174 Null 0.0112425217758227 0.29218433
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0114553853234976 0.0013077097
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0114553853234976 0.35484549
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0114553853234976 0.32119641
NSC 18805 .gamma.-Thujaplicine 0.0114553853234976 0.14429864
NSC 30915 Null 0.0114553853234976 0.37312114
NSC 328410 Camptothecin Derivative 0.0114553853234976 0.036579408
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0114553853234976 0.37635563
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0114553853234976 0.31252296
NSC 359239 Antibiotic X-14766A 0.0114553853234976 -0.20534891
Total:170  Current:59    [First] [Prev] [Next] [Last]